To evaluate decrease in consumption of inhalational anaesthetic agent, sevoflurane with use of a drug dexmedetomidine in laparoscopic cholecystectomy patients by maintaining adequate depth of anaesthesia
Not Applicable
Completed
- Conditions
- Health Condition 1: null- patients undergoing laparoscopic cholecystectomy
- Registration Number
- CTRI/2014/06/004687
- Lead Sponsor
- GMCH Chandigarh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
1.Age group of 18 to 60 years
2.American Society of Anaesthesiologists (ASA) status I and II
Exclusion Criteria
1.Patients with significant cardio respiratory, hepatic or renal insufficiency
2.Patients on beta blockers , anticonvulsants, or any other centrally acting medications
3.Anticipated difficult airway
4.Pregnancy and lactation
5.Patient allergic to the study drug
6.Patients with known neurological disorder
7.Alcohol or substance abuse
8.Patients not willing for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate sevoflurane sparing effect of dexmedetomidine in patients scheduled for laparoscopic cholecystectomy under general anaesthesia. <br/ ><br> <br/ ><br>Timepoint: Every minute during surgery
- Secondary Outcome Measures
Name Time Method hemodynamic parameters and post operative recoveryTimepoint: Every 5 minutes during surgery and at time of shifting patient from PACU to ward